Huang YH, Liu XL, Yang Z. Evaluating the efficacy of interventional hepatocellular carcinoma via dynamic contrast-enhanced magnetic resonance imaging: A retrospective study. World J Gastrointest Oncol 2026; 18(6): 116770 [DOI: 10.4251/wjgo.v18.i6.116770]
Corresponding Author of This Article
Zhao Yang, MD, Department of Diagnostic Radiology, First Affiliated Hospital of Naval Military Medical University, No. 168 Changhai Road, Yangpu District, Shanghai 200433, China. zhaoyang387@163.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
research-article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Huang YH, Liu XL, Yang Z. Evaluating the efficacy of interventional hepatocellular carcinoma via dynamic contrast-enhanced magnetic resonance imaging: A retrospective study. World J Gastrointest Oncol 2026; 18(6): 116770 [DOI: 10.4251/wjgo.v18.i6.116770]
World J Gastrointest Oncol. Jun 15, 2026; 18(6): 116770 Published online Jun 15, 2026. doi: 10.4251/wjgo.v18.i6.116770
Evaluating the efficacy of interventional hepatocellular carcinoma via dynamic contrast-enhanced magnetic resonance imaging: A retrospective study
Ying-Hua Huang, Xin-Liang Liu, Zhao Yang
Ying-Hua Huang, Xin-Liang Liu, Zhao Yang, Department of Diagnostic Radiology, First Affiliated Hospital of Naval Military Medical University, Shanghai 200433, China
Co-first authors: Ying-Hua Huang and Xin-Liang Liu.
Author contributions: Huang YH and Liu XL made equal contributions to this study, produced the report as co-first authors; Liu XL gathered the data; Yang Z directed the study; all the authors evaluated, edited, and approved the final manuscript and revised it critically for essential intellectual content, and agreed to be accountable for all the elements of the work.
Institutional review board statement: This retrospective study was reviewed and approved by the Institutional Review Board of First Affiliated Hospital of Naval Military Medical University (No. SSZ20249-20).
Informed consent statement: This study was a retrospective analysis of previously obtained clinical imaging and medical records, all data were fully anonymized prior to analysis, and no direct patient contact or intervention occurred. In accordance with institutional and national regulations, the Institutional Review Board of First Affiliated Hospital of Naval Military Medical University determined that the requirement for written informed consent was waived.
Conflict-of-interest statement: All authors declare no conflict of interest in publishing the manuscript.
Data sharing statement: The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.
Corresponding author: Zhao Yang, MD, Department of Diagnostic Radiology, First Affiliated Hospital of Naval Military Medical University, No. 168 Changhai Road, Yangpu District, Shanghai 200433, China. zhaoyang387@163.com
Received: December 12, 2025 Revised: January 15, 2026 Accepted: March 3, 2026 Published online: June 15, 2026 Processing time: 178 Days and 18.6 Hours
Core Tip
Core Tip: To evaluate the efficacy of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in interventional therapy for hepatocellular carcinoma (HCC). DCE-MRI, as an advanced imaging technique, can provide dynamic information on tumor blood flow, perfusion and microvascular permeability, which is highly important for the diagnosis and therapeutic evaluation of HCC. By analyzing the DCE-MRI data of patients, this study focused on investigating the changes in blood flow and drug delivery characteristics of tumors before and after interventional therapy. The research results show that DCE-MRI can effectively reflect the effect of interventional treatment for HCC and provide a more accurate basis for evaluating clinical efficacy. Furthermore, the high-resolution and multiparameter characteristics of DCE-MRI enable it to demonstrate unique advantages in monitoring the process of tumor treatment, especially in the early assessment of small liver cancer.
